Abstract
Synthetic approaches to daunorubicin derivatives containing azide and propargyl fragments were developed. A series of phosphonate and bisphosphonate derivatives (including those containing P–C–P fragments) were obtained by the methods of click chemistry and by direct amidation. The obtained compounds show small cytotoxicity not higher than that of parent daunorubicin.
Similar content being viewed by others
References
Mross K, Massing U, Kratz F. DNA-intercalators – the anthracyclines. In: Pinedo HM, Smorenburg CH, editors. Drugs Affecting Growth of Tumours. p. 19–81. https://doi.org/10.1007/3-7643-7407-1. (2006)
Cassinelli G. The roots of modern oncology: from discovery of new antitumor anthracyclines to their clinical use. Tumor J. 2016;3:226–35.
Yu S, Zhang G, Zhang W, Luo H, Qiu L, Liu Q, et al. Synthesis and biological activities of a 3’-azido analogue of doxorubicin against drug-resistant cancer cells. Mol Sci. 2012;13:3671–84.
Seshadri R, Israel M, William PJ. Adriamycin analogs. Preparation and biological evaluation of some novel 14-thiaadriamycins. J Med Chem. 1983;26:11–5.
Zhang G, Fang L, Zhu L, Sun D, Wang PG. Synthesis and biological activity of bisdaunorubicins. Bioorg Med Chem. 2006;14:426–34.
Chaires JB, Leng F, Przewloka T, Fokt I, Ling Y-H, Perez-Soler R, et al. Structure-based design of a new bisintercalating anthracycline antibiotic. J Med Chem. 1997;40:261–66.
Seshadri R, Idriss JM, Israel M. Preparation and biological evaluation of some thio ester analogues of adriamycin and N-(trifluoroacetyl)adriamycin 14-valerate. J Med Chem. 1986;29:1269–73.
Ghirmai S, Mume E, Tolmachev V, Sjoberg S. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives. Carbohydr Res. 2005;340:15–24.
Zhang S-J, Dong J-Q, Wang Y-G. Synthesis and biological activities of novel seleno epi-daunomycin derivatives. Synth Commun. 2003;33:1891–8.
Sharova EV, Artyushin OI, Vinogradova NV, Genkina GK, Brel VK. Synthesis of hybrid compounds composed of daunorubicin covalently liked with Cp2Fe and CpMn(CO)3. Mendeleev Commun. 2017;27:608–9.
Preobrazhenskaya N. Developments in the research of new antitumor agents (review). Khim Geterotsikl Soedin. 1985;1:18–31.
Martins-Teixeira MB, Carvalho I. Antitumor anthracyclines: progress and perspectives. ChemMedChem. 2020;15:933–48.
David E, Cagnol S, Goujon J-Y, Egorov M, Taurelle J, Benesteau C, et al. 12b80 – hydroxybisphosphonate linked doxorubicin: bone targeted strategy for treatment of osteosarcoma. Bioconjugate Chem. 2019;30:1665–76.
Protsenko LD, Shapiro AB, Ovrutskii VM, Suskina VI, Vasil’eva LS, Denisova LK, et al. Synthesis and biological activity of organophosphorus derivatives of rubomycine with bis(2-chlorethyl)amino groups. Khim Farm Zh . 1985;19:1199–202.
Csorvasi A, Kover KE, Menyhart MM, Sztaricskai F, Dobrynin YV, Nikolaeva TG. Synthesis of phosphoramide mustard analogues of daunomycin and carminomycin. Arch Pharm. Med Chem. 1998;331:265–8.
Kim JS, Sharma A, Lee MG, Won M, Lee JY, Chi S-G, et al. Anticancer prodrug for overcoming drug resistance. US20200129626. 2018 October 24.
Vorobyeva DV, Karimova NM, Odinets IL, Röschenthaler G-V, Osipov SN. Click-chemistry approach to isoxazole-containing α-CF3-substituted α-aminocarboxylates and α-aminophosphonates. Org Biomol Chem. 2011;9:7335–42.
Skarpos H, Osipov SN, Vorob’eva DV, Odinets IL, Lork E, Röschenthaler G-V. Synthesis of functionalized bisphosphonates via click chemistry. Org Biomol Chem. 2007;5:2361–7.
Omiecinski CJ, Heuvel JPV, Perdew GH, Peters JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci. 2010;120:S49–S75.
Shiryaeva OA, Semenova NA, Sibeldina LA, Goncharova SA, Konovalova NP. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells. Neoplasma. 1992;39:229–32.
Piotrowska DG, Andrei G, Schols D, Snoeck R, Grabkowska-Druzyc M. New isoxazolidine-conjugates of quinazolinones – synthesis, antiviral and cytostatic activity. Molecules. 2016;21:1–15.
Chrobak E, Bębenek E, Kadela-Tomanek M, Latocha M, Jelsch C, Wenger E, et al. Betulin phosphonates; synthesis, structure, and cytotoxic activity. Molecules. 2016;21:1123.
Tsepaeva OV, Nemtarev AV, Abdullin TI, Grigor’eva LR, Kuznetsova EV, Akhmadishina RA, et al. synthesis, and cancer cell growth inhibitory activity of triphenylphosphonium derivatives of the triterpenoid botulin. J Nat Prod. 2017;80:2232–9.
Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem Int Ed. 2001;40:2004–21.
Artyushin OI, Sharova EV, Vinogradova NM, Genkina GK, Moiseeva AA, Klemenkova ZV, et al. Synthesis of camfphaecene derivatives using clic chemistry methodology and study of their antiviral activity. Bioorg Med Chem Lett. 2017;27:2181–4.
Tong GL, Wu HY, Henry DW. Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicity. J Med Chem. 1979;22:912–8.
Gil JM, Hah JH, Park KY, Oh DY. A facile synthesis of diethyl 1-formylalkane phosphonates via ozonolysis of 1-alkyl allylic phosphonates. Synth Commun. 2000;30:789–94.
Masquelier M, Tirzitis G, Peterson CO, Palsson M, Amolins A, Plotniece M, et al. Plasma stability and cytotoxicity of lipophilic daunorubicin derivatives incorporated into low density lipoproteins. Eur J Med Chem. 2000;35:429–38.
Mielczarek-Puta M, Struga M, Roszkowski P. Synthesis and anticancer effects of conjugates of doxorubicin and unsaturated fatty acids (LNA and DHA). Med Chem Res. 2019;28:2153–64.
Baszczynski O, Watt JM, Rozewitz MD, Fliegert R, Gusec AH, Potter BVL. Synthesis of phosphonoacetate analogues of the second messenger adenosine 50 –diphosphate ribose (ADPR). RSC Adv 2020;10:1776–85.
Patel DV, Schmidt RJ, Biller SA, Gordon EM, Robinson SS, Manne V. Farnesyl diphosphate-based inhibitors of ras farnesyl protein transferase. J Med Chem. 1995;38:2906–21.
Anikina LV, Semakov AV, Afanas’eva SV, Pukhov SA, Klochkov SG. Synthesis and antiproliferative activity of daunorubicin conjugates with sesquiterpene lactones. Pharm Chem J. 2018;52:308–11.
Brel VK, Artyushin OI, Chuprov-Netochin RN, Leonov SV, Semenova MN, Semenov VV. Synthesis and biological evaluation of indolylglyoxylamide bisphosphonates, antimitotic microtubule-targeting derivatives of indibulin with improved aqueous solubility. Bioorg Med Chem Lett. 2020;30:127635.
Brel VK, Moiseeva AA, Artyushin OI, Anikina LV, Klemenkova ZS. Simple methods of modification of daunorubicin on the daunosamine nitrogen atom. Med Chem Res. 2021;30:564–73.
Artyushin OI, Vorob’eva DV, Vasil’eva TP, Osipov SN, Roschenthaler G-V, Odinets IL. Facile synthesis of phosphorylated azides in ionic liquids and their use in the preparation of 1,2,3-triazoles. Het Chem. 2008;19:293–300.
Ziegler FE, Fowler KW, Rodgers WB, Wester RT. Ambient-temperature Ullman reaction: 4,5,4’,5’-tetramethoxy-1,1’-biphenyl-2,2’-dicarboxaldehyde. Org Syntheses. 1993;VIII:586–93.
Castaneda L, Maruani A, Schumacher FF, Miranda E, Chudasama V, Chester KA, et al. Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation. Chem Commun. 2013;49:8187–9.
González-Méndez I, Aguayo-Ortiz R, Sorroza-Martínez K, Solano JD, Porcu P, Rivera E, et al. Conformational analysis by NMR and molecular dynamics of adamantanedoxorubicin prodrugs and their assemblies with β-cyclodextrin: a focus on the design of platforms for controlled drug delivery. Bioorg Med Chem. 2020;28:115510.
Acknowledgements
This work was supported by the Ministry of Science and Higher Education of the Russian Federation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no cmpeting interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
About this article
Cite this article
Moiseeva, A.A., Artyushin, O.I., Anikina, L.V. et al. N-Phosphorylation of daunorubicin—synthetic approaches and antiproliferative properties of the products. Med Chem Res 31, 1011–1025 (2022). https://doi.org/10.1007/s00044-022-02889-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-022-02889-9